Amb a 1 immunostimulatory oligodeoxyribonucleotide conjugate - Dynavax
Alternative Names: 1018 ISS ragweed allergen conjugate; AIC; Amb a 1 Immunostimulatory Conjugate; Amb a 1 ISS; Amb a 1 ISS 1018; Amb a 1 ISS DNA; ISS 1018 ragweed allergen conjugate; ISS ragweed allergen conjugate; ISS ragweed allergen conjugate Dynavax; ragweed allergen 1018 ISS conjugate; ragweed allergen ISS conjugate; Ragweed allergy immunotherapy 1018 ISS conjugate; Ragweed allergy vaccine 1018 ISS conjugate; ragweed allergy vaccine ISS conjugate; Ragweed protein linked ISS; TOLAMBALatest Information Update: 02 Oct 2021
Price :
$50 *
At a glance
- Originator Dynavax Technologies
- Class Allergens; Antiallergics; DNA vaccines; Oligonucleotides; Plant allergy immunotherapies
- Mechanism of Action Immunomodulators; Toll-like receptor 9 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Seasonal allergic rhinitis
Most Recent Events
- 20 May 2008 Discontinued - Phase-II for Seasonal allergic rhinitis in Canada (SC)
- 24 Oct 2007 Phase-II clinical trials for Seasonal allergic rhinitis in Canada (SC)
- 08 Mar 2007 No development reported - Phase-II/III for Seasonal allergic rhinitis in Canada (SC)